TRANSFERS OF FROZEN - THAWED HUMAN EMBRYOS IN CYCLES STIMULATED BY HMG

被引:18
作者
LORNAGE, J
BOULIEU, D
MATHIEU, C
GUERIN, JF
PINATEL, MC
JAMES, R
ALVARADO, C
机构
[1] Laboratoire de Biologie, La Reproduction et du Développement, 69437 Lyon Cedex 03, Place d'Arsonval
[2] Clinique de Gynécologic L'H6pital Edouard Herriot, 69437 Lyon Cedex 03, Place d'Arsonval
关键词
Analogue; Cryopreservation; Human embryo quality; LHRH;
D O I
10.1093/oxfordjournals.humrep.a137042
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
A total of 130 transfers of frozen-thawed (F-T) human embryos was carried out after moderate ovarian stimulation with human menopausal gonadotrophin (HMG). Embryos were replaced 3 days after the spontaneous luteinizing hormone (LH) surge or 4 days if ovulation was induced by human chorionic gonadotrophin (HCG). Embryos were thawed a few hours prior to transfer. One-hundred-and-twenty-three transfers were effective and 23 pregnancies were achieved. The rate of ongoing pregnancies per transfer was 17.9% (22/123). The survival rate of embryos originating from cycles stimulated by a combination of an LHRH analogue and HMG in a long protocol (LA-HMG protocol) was significantly lower when compared with the rate of embryos retrieved from clomiphene citrate-HMG (CC-HMG protocol) stimulated cycles (52 versus 67%, P > 0.05). When fresh embryos originated from cycles stimulated with an LHRH analogue and HMG in a short protocol (SA-HMG protocol), the survival rate was not affected (59 versus 67%, NS). Although the difference was not significant, the ongoing pregnancy rate per transfer according to the three protocols from which the embryos originated seemed to be better with the SA-HMG protocol: 16% with the CC-HMG protocol, 14.5% with the LA-HMG protocol versus 27.6% with the SA-HMG protocol The success rate was independent of the number of F-T transferred embryos if at least one embryo with 100% intact blastomeres was replaced. © 1990 Oxford University Press.
引用
收藏
页码:60 / 65
页数:6
相关论文
共 24 条
[11]  
Mandelbaum J., Junca A.M., Plachot M., Alnot M.O., Alvarez S., Debache C., Salat-Baroux J., Cohen J., Human embryo cryopreservation, extrinsic and intrinsic parameters of success, Hum. Reprod, 2, pp. 709-715, (1987)
[12]  
Mandelbaum J., Junca A.M., Plachot M., Alnot M.O., Tibi C., Cohen J., Salat-Baroux J., Cryopreservation of human embryos and oocytes using 1, 2-propanediol with or without sucrose as cryoprotectnve agent, Workshop on Embryo and Ooocyte Freezing, pp. 95-105, (1986)
[13]  
Mandelbaum J., Junca A.M., Plachot M., Alnot M.O., Salat-Baroux J., Alvarez S., Tibi C., Cohen J., Debache C., Tesquier L., Cryopreservation of human embryos and oocytes, Hum. Reprod, 3, pp. 117-119, (1988)
[14]  
Porter R.N., Smith W.I., Craft I.L., Abdulwahid N.A., Jacobs H.S., Induction of ovulation for in vitro fertilization using Buserelin and gonadotrophins, Lancet, 2, (1984)
[15]  
Quinn P., Kerin J., Experience with the cryopreservation of human embryos using the mouse as a model to establish successful techniques. J, Vitro Fertil. Embryo Transfer, 3, pp. 40-45, (1986)
[16]  
Testart J., Lassalle B., Belaisch-Allart J., Hazout A., Forman R., Rainhom D., Frydman R., High pregnancy rate after early human embryo freezing, Fertil. Steril, 46, (1986)
[17]  
Testart J., Lassalle B., Forman R., Gazengel A., Belaisch-Allart J., Hazout A., Rainhom J.D., Frydman R., Factors influencing the success rate of human embryo freezing in an in-vitro fertilization and embryo transfer program, Fertil. Steril, 48, pp. 107-112, (1987)
[18]  
Testart J., Belaisch-Allart J., Volante M., Gazengel A., Gazagne I., Forman R., Strubb N., Hazout A., Frydman R., Effet du traitement avec agonistes du GnRH sur le nombre et la quality des embryons et sur la r&eptivit£ de I'uterus. Contracept, Fertil. Sexual, 16, pp. 669-670, (1988)
[19]  
Trounson A., Preservation of human eggs and embryos, Fertil. Steril, 46, (1986)
[20]  
Trounson A., Mohr L., Human pregnancy following cryopreservation, thawing and transfer of an eight-cell embryo, Nature, 305, (1983)